With a market cap of $122.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) operates as a global biotechnology company ...

Vertex Pharmaceuticals ( VRTX 2.72%) had a fine Tuesday on the stock exchange. The biotech 's shares closed the day nearly 3% ...

Vertex Pharmaceuticals made headlines with a 14% share price jump, despite an overall market dip, thanks to clinical wins and ...

A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ETFs? The ...

Canada Gairdner Awards recognize the world’s most accomplished researchers whose work is improving our understanding of human ...

Vertex Pharmaceuticals has been the apple of investors’ search engines, but its recent stock dip of 3.3% might have folks scratching their heads. Zacks notes that while the broader biomedical industry ...

Drug firms Glenmark and Biocon are recalling products in the US for manufacturing issues, according to the US health regulator. New Jersey-based Glenmark Pharmaceuticals Inc is recalling 8,160 bottles ...

Shares of Vertex Pharmaceuticals Inc. VRTX rose 2.10% to $482.30 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 9.52% ...

In such cases, the manufacturer is required to take corrective action, which may include removing the product from the market or addressing the violation. Shares of Glenmark Pharmaceuticals Ltd. are ...

Trump said at the dinner: "We're going to be announcing very shortly a major tariff on pharmaceuticals. And when they hear that, they will leave China. They will leave other places because they have ...

net product revenues, strengthening our balance sheet and continued delivery of strong operating margins,” wrote Vertex. The company added that Kewalramani delivered “exemplary leadership ...

EU medical and pharmaceutical product exports to the United States totalled about 90 billion euros ($97.05 billion) in 2023, according to latest Eurostat data. European pharma giants have recently ...